> top > docs > PubMed:26684240 > spans > 973-1167 > annotations

PubMed:26684240 / 973-1167 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
11005 6-13 DiseaseOrPhenotypicFeature denotes GEP-NET MESH:C535650
11006 14-22 OrganismTaxon denotes patients NCBITaxon:9606
11007 28-32 GeneOrGeneProduct denotes TP53 NCBIGene:7157
11008 89-115 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET MESH:D007414
11009 116-123 OrganismTaxon denotes patient NCBITaxon:9606
11010 129-133 GeneOrGeneProduct denotes BRAF NCBIGene:673
11011 134-139 SequenceVariant denotes V600E DBSNP:rs113488022
11012 174-183 ChemicalEntity denotes pazopanib MESH:C516667

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T7 0-194 Sentence denotes Three GEP-NET patients with TP53 mutations demonstrated a durable response and one small intestinal grade (G) 1 NET patient with BRAF V600E mutation showed progression after pazopanib treatment.

LitCoin-SeqVar

Id Subject Object Predicate Lexical cue
T2 134-139 SequenceVariant denotes V600E

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T23 10-13 GeneOrGeneProduct denotes NET
T24 28-32 GeneOrGeneProduct denotes TP53
T25 83-88 GeneOrGeneProduct denotes small
T26 89-99 GeneOrGeneProduct denotes intestinal
T27 112-115 GeneOrGeneProduct denotes NET
T28 129-133 GeneOrGeneProduct denotes BRAF

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T46 10-13 GeneOrGeneProduct denotes NET
T47 28-32 GeneOrGeneProduct denotes TP53
T48 33-42 GeneOrGeneProduct denotes mutations
T49 83-88 GeneOrGeneProduct denotes small
T50 89-99 GeneOrGeneProduct denotes intestinal
T51 112-115 GeneOrGeneProduct denotes NET
T52 129-133 GeneOrGeneProduct denotes BRAF
T53 140-148 GeneOrGeneProduct denotes mutation

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T22 10-13 GeneOrGeneProduct denotes NET
T23 28-32 GeneOrGeneProduct denotes TP53
T24 112-115 GeneOrGeneProduct denotes NET
T25 129-133 GeneOrGeneProduct denotes BRAF

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T8 6-13 DiseaseOrPhenotypicFeature denotes GEP-NET 0024503

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T8 6-13 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T9 89-115 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T8 6-13 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T9 89-115 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T3 174-183 ChemicalEntity denotes pazopanib C516667|http://purl.obolibrary.org/obo/CHEBI_71219

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T2 14-22 OrganismTaxon denotes patients
T3 116-123 OrganismTaxon denotes patient

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T3 174-183 ChemicalEntity denotes pazopanib http://purl.obolibrary.org/obo/CHEBI_71219|C516667
T25 129-133 GeneOrGeneProduct denotes BRAF
T24 112-115 GeneOrGeneProduct denotes NET
T23 28-32 GeneOrGeneProduct denotes TP53
T22 10-13 GeneOrGeneProduct denotes NET
T48673 89-115 DiseaseOrPhenotypicFeature denotes intestinal grade (G) 1 NET DISEASE
T20286 6-13 DiseaseOrPhenotypicFeature denotes GEP-NET DISEASE
T57822 116-123 OrganismTaxon denotes patient
T87458 14-22 OrganismTaxon denotes patients
T55890 134-139 SequenceVariant denotes V600E